PMI · Picard Medical, Inc.
$0.09
+0.00 (+0.11%)
At close · Jul 23
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our independent registered public accounting firm has included an explanatory paragraph relating to our ability to continue as a going concern in its report on our audited financial statements”View the 10-Q filed May 15, 2026
Market Cap
$8.12M
Shares
92.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.09
Open$0.09
Day$0.09–0.09
52W$0.09–13.68
Avg vol 30d23.8M
Short int15.4M · 16.7% float · 1.0d
Short vol43%
Last earningsMar 25, 2026
DataAug 2025–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−95%
below
Price vs 50-day avg
−49%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−48%
trailing
6-month return
−95%
trailing
YTD return
−95%
this year
Relative strength
−101%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
9 of 40 funds reported for Jun 30 · net +134.9K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
16.67% of float · ▲ +358.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
+13%
Y/Y
Gross margin
-4%
contracting
Balance sheet
$7.5M
net cash
Quant / Vol
risk profile
Volatility
186%
annualized · 1-yr
Max drawdown
−99%
past year
ATR
31.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−95%
Bearish
Price vs 50-day avg
−49%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
9 of 40 funds reported for Jun 30 · net +134.9K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
16.67% of float · ▲ +358.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $14
vs 200-day avg -95%
vs 50-day avg -49%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PMI
this stock
Picard Medical, Inc.
|
$8.12M | -95.0% | — | — | 16.7% |
|
ABT
Abbott Laboratories
|
$179.51B | -19.2% | +5.7% | 28.9 | 1.4% |
|
SYK
Stryker Corp
|
$126.60B | -9.0% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$106.51B | -13.9% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.77B | -54.3% | +5.5% | 18.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PMI | -45.0% | -48.2% | -95.1% | -46.3% | -95.0% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -43.3% | -48.9% | -101.5% | -45.2% | -103.2% |